Study Comparing Risperidone vs Placebo as Add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-Optimally Responding to Standard Therapy.
This study has been completed.
Study NCT00086112
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: June 24, 2004
Last Updated: April 23, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
